Equillium (EQ) Receivables - Other (2022 - 2025)

Equillium (EQ) posted quarterly Receivables - Other of $108000.0 for Q4 2025, down 39.33% year-over-year from $178000.0 in Q4 2024, and down 12.2% quarter-over-quarter from $123000.0 in Q3 2025.

Equillium (EQ) Receivables - Other (2022 - 2025) Analysis & Trends

Equillium (EQ) has reported Receivables - Other for 4 consecutive years, with $108000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Receivables - Other fell 39.33% year-over-year to $108000.0; the TTM figure through Dec 2025 stood at $108000.0 (down 39.33% YoY), while the FY2025 annual figure was $108000.0, down 39.33% from the prior year.
  • Receivables - Other declined to $108000.0 in Q4 2025 per EQ's latest filing, from $123000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $497000.0 in Q4 2023 and bottomed at $35000.0 in Q2 2025.
  • Historically, Receivables - Other has averaged $245200.0 across 4 years, with a median of $223500.0 in 2022.
  • Annual changes were most pronounced in 2023 — Receivables - Other soared 84.76% — and 2025, when it sank 91.4%.
  • Equillium's Receivables - Other stood at $269000.0 in 2022, then jumped by 84.76% to $497000.0 in 2023, then slumped by 64.19% to $178000.0 in 2024, then plunged by 39.33% to $108000.0 in 2025.
  • Business Quant data shows EQ's Receivables - Other at $108000.0 in Q4 2025, $123000.0 in Q3 2025, and $35000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Equillium 263.86 Mn 263.86 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 108,000.00
Dec 31, 2025 108,000.00
Sep 30, 2025 123,000.00
Sep 30, 2025 123,000.00
Jun 30, 2025 35,000.00
Jun 30, 2025 35,000.00
Mar 31, 2025 73,000.00
Mar 31, 2025 73,000.00
Dec 31, 2024 178,000.00
Dec 31, 2024 178,000.00
Sep 30, 2024 275,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 407,000.00
Jun 30, 2024 407,000.00
Mar 31, 2024 487,000.00
Mar 31, 2024 487,000.00
Dec 31, 2023 497,000.00
Dec 31, 2023 497,000.00
Dec 31, 2022 269,000.00
Dec 31, 2022 269,000.00